C4 Therapeutics Inc

XNAS: CCCC

Weak Stock

Download real time

1.37 -0.13 (-8.67%)

82.11% Fall from 52W High

679.5K XNAS Volume

XNAS 14 May, 2025 4:00 PM (EDT)

97.3

Market Cap

Below industry Median

0.3

Beta 1Year

Very Low volatility

C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 8 analysts

C4 Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of -36.1%, and profit growth estimate of -14.7% for FY25, based on top 8 analyst calls.

Forecaster Screeners